The combined anti-tumor effect was attributed to increased CD8+ T cell infiltration, downregulation of the anti-apoptotic protein Bcl2, and concurrent upregulation of the pro-apoptotic Bax protein [250]. The gene discussed is CD8A; the disease is neoplasm.